Jossy Onwude, MD Published Apr 16, 2026 24 min read The short version: On April 15, 2026, the FDA announced it will convene an advisory panel in July to review seven restricted peptides including BPC-157 and TB-500 and decide whether they can be legally compounded again
Known for its regenerative properties, BPC-157 aids in tissue repair of skeletal muscle, soft tissue, tendons and ligaments by accelerating the formation of new blood vessels and collagen
The product appears as a clear, colorless solution with no visible particles
Only a straight-on, eye-level reading gives an accurate result
Because energy expenditure is increased within fat cells, the rate of cellular metabolism within these fat cells go up
A 2025 systematic review in the HSS Journal identified 36 studies from 1993 to 2024, with consistent findings across multiple animal models and injury types